These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 29950604)

  • 21. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality.
    Shivaji UN; Ford AC
    Prim Health Care Res Dev; 2015 May; 16(3):263-9. PubMed ID: 25287958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
    Chlebicz-Wójcik A; Śliżewska K
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
    Currò D; Ianiro G; Pecere S; Bibbò S; Cammarota G
    Br J Pharmacol; 2017 Jun; 174(11):1426-1449. PubMed ID: 27696378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irritable bowel syndrome - The role of complementary medicines in treatment.
    Pirotta M
    Aust Fam Physician; 2009 Dec; 38(12):966-8. PubMed ID: 20369148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Irritable bowel treatment].
    Fassov J; Fynne L; Krarup AL
    Ugeskr Laeger; 2016 Aug; 178(35):. PubMed ID: 27592867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for irritable bowel syndrome.
    Med Lett Drugs Ther; 2016 Sep; 58(1504):121-6. PubMed ID: 27649342
    [No Abstract]   [Full Text] [Related]  

  • 27. Irritable bowel syndrome: assessment and management.
    Boyd-Carson W
    Nurs Stand; 2004 Sep 8-14; 18(52):47-52; quiz 54-5. PubMed ID: 15473209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuances in treating irritable bowel syndrome.
    Frissora CL
    Rev Gastroenterol Disord; 2007; 7(2):89-96. PubMed ID: 17597676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
    Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 54-year-old woman with constipation-predominant irritable bowel syndrome.
    Lembo AJ
    JAMA; 2006 Feb; 295(8):925-33. PubMed ID: 16493106
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnosis and therapy of irritable bowel syndrome.
    De Giorgio R; Barbara G; Stanghellini V; Cremon C; Salvioli B; De Ponti F; Corinaldesi R
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():10-22. PubMed ID: 15335409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prebiotics and Probiotics for Gastrointestinal Disorders.
    Rau S; Gregg A; Yaceczko S; Limketkai B
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symbiotics in irritable bowel syndrome--better than probiotics alone?
    Gracie DJ; Ford AC
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):485-9. PubMed ID: 26107141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.
    Mozaffari S; Nikfar S; Abdollahi M
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):403-21. PubMed ID: 23330973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Talley NJ; Spiegel BM; Foxx-Orenstein AE; Schiller L; Quigley EM; Moayyedi P
    BMJ; 2008 Nov; 337():a2313. PubMed ID: 19008265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
    Shah E; Kim S; Chong K; Lembo A; Pimentel M
    Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial: The importance of systematic reviews and meta-analyses of probiotics and prebiotics.
    Whelan K
    Am J Gastroenterol; 2014 Oct; 109(10):1563-5. PubMed ID: 25287086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.
    Ford AC; Moayyedi P; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Quigley EM;
    Am J Gastroenterol; 2014 Aug; 109 Suppl 1():S2-26; quiz S27. PubMed ID: 25091148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.